Join the club for FREE to access the whole archive and other member benefits.

Matthias Steger

Biotech Entrepreneur and co-founder and Chief Executive Officer at Rejuveron Life Sciences

Matthias has more than 20 years pharma / biotech experience and is the co-founder of Endogena Therapeutics. As former global head of research and technology partnering at Roche, Matthias set up and managed > 50 collaborations and acquisitions for novel drug modalities, drug discovery technologies and enabling technologies. He also established Roche’s stem cell research programme. An entrepreneur at heart, Matthias set up a pioneering orphan G-protein coupled receptor (GPCR) drug discovery company, which resulted in a successful acquisition. He gained financial experience as an investment banking analyst at Kepler Equities.

Visit website: https://rejuveron.com/en/who-we-are#people

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company Rejuveron - Company that develops and invests in drugs and technologies which prolong human lifespan.

Matthias Steger is also referenced in the following:

Event
Longevity Leaders World Congress 2022
26-Feb-2022 to 27-Feb-2022

Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)

Event

Symposium about healthy living organized by Rejuveron (FREE)